ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Retrospective Study |
Article Title |
Diagnostic and economic value of carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 72-4 in gastrointestinal cancers
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Hai-Ning Liu, Can Yao, Xiao-Fan Wang, Ning-Ping Zhang, Yan-Jie Chen, Dong Pan, Guo-Ping Zhao, Xi-Zhong Shen, Hao Wu and Tao-Tao Liu |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Tao-Tao Liu, MD, Doctor, Doctor, Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai 200032, China. liu.taotao@zs-hospital.sh.cn |
Key Words |
Diagnostic test; Economic analysis; Cost-effectiveness analysis; Decision curve analysis |
Core Tip |
This is a retrospective study to reassess the diagnostic and economic value of traditional tumor biomarkers carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9) and CA72-4 for gastrointestinal malignant tumors in a large sample with novel indicators. Instead of increasing the diagnostic value, CA72-4 should be removed from the list of the health checkup items to avoid the waste of social medical resources for CEA were superior to those of CA19-9, CA72-4 or any other combinations in which it could be applied for early colorectal cancer and a health checkup of CEA for people above 65 years old was economically valuable. |
Publish Date |
2023-01-20 13:48 |
Citation |
Liu HN, Yao C, Wang XF, Zhang NP, Chen YJ, Pan D, Zhao GP, Shen XZ, Wu H, Liu TT. Diagnostic and economic value of carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 72-4 in gastrointestinal cancers. World J Gastroenterol 2023; 29(4): 706-730 |
URL |
https://www.wjgnet.com/1007-9327/full/v29/i4/706.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v29.i4.706 |